lysyl-aspartyl-glutamyl-leucine has been researched along with Cancer of Ovary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y; Jiao, P; Ren, Y; Wei, D; Zhang, J | 1 |
| Cohen, M; Delie, F; Petignat, P; Ribaux, P | 1 |
2 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and Cancer of Ovary
| Article | Year |
|---|---|
Construction and characterization of the recombinant immunotoxin RTA-4D5-KDEL targeting HER2/neu-positive cancer cells and locating the endoplasmic reticulum.
Topics: Amino Acid Motifs; Cell Line, Tumor; Endoplasmic Reticulum; Female; HEK293 Cells; Humans; Immunotoxins; Lung Neoplasms; Oligopeptides; Ovarian Neoplasms; Protein Sorting Signals; Protein Transport; Receptor, ErbB-2; Recombinant Fusion Proteins; Ricin; Single-Chain Antibodies | 2018 |
Anti-KDEL-coated nanoparticles: a promising tumor targeting approach for ovarian cancer?
Topics: Antibodies, Monoclonal; Apoptosis; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Female; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Membrane Proteins; Molecular Targeted Therapy; Nanoparticles; Neoplasm Invasiveness; Oligopeptides; Ovarian Neoplasms; Paclitaxel; Protein Sorting Signals | 2012 |